SXTC logo

China SXT Pharmaceuticals, Inc.

SXTC
Healthcare|Drug Manufacturers - Specialty & Generic|CN
$2.83
-0.10 (-3.41%)
DCF Value
$3537.77
Tangible Book / Share
$5070.18
Cash / Share
$4809.87

About

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

Stock Price

-100.0%(1Y)
1M
-91.8%
3M
-99.2%
6M
-100.0%
YTD
-100.0%
1Y
-100.0%
3Y
-100.0%
5Y
-100.0%

Pipeline Summary

0 total trials
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4

Key Facts

Market Cap$15.1K
Employees56
CEOFeng Zhou
IPO DateJan 4, 2019
Beta2.02
52-Week Range$2.71 – $8376000
Avg Volume14,384,368
ExchangeNASDAQ

Ownership

Float82.5%
Shares Outstanding0.0M

Recent Insider Trades

Pan Xiaodong SeanOTHER
Jan 31, 20220 shares
Zhou Feng FelixOTHER
Jul 4, 20170 shares
Chee Yong LipOTHER
Jan 20, 20250 shares
Ji XiaodongOTHER
May 22, 20210 shares
Liu Tong TonyOTHER
May 10, 20220 shares

Peers

ATLNAtlantic International Corp.
$68.6M
AVRAnteris Technologies Global Corp.
$554.5M
CYBNCybin Inc.
$413.0M
FATEFate Therapeutics, Inc.
$213.9M
IPHAInnate Pharma S.A.
$157.3M
IXHLIncannex Healthcare Limited
$26.8M
MISTMilestone Pharmaceuticals Inc.
$95.0M
NVCTNuvectis Pharma, Inc.
$682.6M
Data last updated: Nov 9, 2026, 04:35 AM